Sickle Cell Disease: Ex Vivo Cell Therapy Shines in Early Study

]]>(MedPage Today) -- ORLANDO--Transforming sickle cell disease patients' marrow cells ex vivo to promote production of fetal hemoglobin in place of defective forms of the oxygen-carrying protein was safe and showed strong signs of durable efficacy...